Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104429 · ClinicalTrials.gov registry record · Phase 2
GW873140 In Combination With Combivir In HIV Infected Subjects
A Phase 2 study, sponsored by ViiV Healthcare.
- Terminated
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT00104429 is a Phase 2 study that was terminated before completion, run by ViiV Healthcare. The registered enrollment target is 125 participants.
The verdict
NCT00104429, a Phase 2 study, was terminated before completion, sponsored by ViiV Healthcare.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.
Interventions
- DRUG Combivir
- DRUG GW873140
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00104429
The ClinicalTrials.gov registry entry for NCT00104429 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Combivir is the first listed.
NCT00104429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00104429 about?
NCT00104429 is a clinical study titled "GW873140 In Combination With Combivir In HIV Infected Subjects". This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.
What is the current status of trial NCT00104429?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2005-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00104429?
The interventions under investigation include: Combivir (DRUG), GW873140 (DRUG).
Who is sponsoring clinical trial NCT00104429?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.